Kowal Investment Group LLC Purchases 319 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Kowal Investment Group LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 27.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,488 shares of the healthcare conglomerate’s stock after acquiring an additional 319 shares during the quarter. Kowal Investment Group LLC’s holdings in UnitedHealth Group were worth $870,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Swedbank AB acquired a new position in UnitedHealth Group during the first quarter worth $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Lone Pine Capital LLC bought a new position in UnitedHealth Group during the second quarter worth about $480,903,000. Dimensional Fund Advisors LP raised its stake in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after buying an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. raised its stake in UnitedHealth Group by 1,125.4% in the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after acquiring an additional 821,050 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $571.30 on Thursday. The stock has a market cap of $527.55 billion, a PE ratio of 37.88, a P/E/G ratio of 1.69 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The business’s 50-day moving average price is $584.21 and its two-hundred day moving average price is $532.84.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.56 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 55.70%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on UNH shares. Robert W. Baird increased their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Wells Fargo & Company upped their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Truist Financial restated a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price for the company. Finally, Royal Bank of Canada lowered their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $615.16.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.